| Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci FR Schumacher, AA Al Olama, SI Berndt, S Benlloch, M Ahmed, ... Nature genetics 50 (7), 928-936, 2018 | 885 | 2018 |
| Genetic mechanisms of immune evasion in colorectal cancer CS Grasso, M Giannakis, DK Wells, T Hamada, XJ Mu, M Quist, JA Nowak, ... Cancer discovery 8 (6), 730-749, 2018 | 462 | 2018 |
| Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction DV Conti, BF Darst, LC Moss, EJ Saunders, X Sheng, A Chou, ... Nature genetics 53 (1), 65-75, 2021 | 391 | 2021 |
| Dietary flavonoid intake, black tea consumption, and risk of overall and advanced stage prostate cancer MS Geybels, BAJ Verhage, ICW Arts, FJ Van Schooten, RA Goldbohm, ... American journal of epidemiology 177 (12), 1388-1398, 2013 | 115 | 2013 |
| Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants T Dadaev, EJ Saunders, PJ Newcombe, E Anokian, DA Leongamornlert, ... Nature communications 9 (1), 2256, 2018 | 110 | 2018 |
| Epigenome-wide tumor DNA methylation profiling identifies novel prognostic biomarkers of metastatic-lethal progression in men diagnosed with clinically localized prostate cancer S Zhao, MS Geybels, A Leonardson, R Rubicz, S Kolb, Q Yan, B Klotzle, ... Clinical Cancer Research 23 (1), 311-319, 2017 | 96 | 2017 |
| Genetic mechanisms of immune evasion in colorectal cancer. Cancer Discov. 2018; 8: 730–749. doi: 10.1158/2159-8290 CS Grasso, M Giannakis, DK Wells, T Hamada, XJ Mu, M Quist, JA Nowak, ... CD-17-1327.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 85 | |
| Validation of distinct type 2 diabetes clusters and their association with diabetes complications in the DEVOTE, LEADER and SUSTAIN‐6 cardiovascular outcomes trials AR Kahkoska, MS Geybels, KR Klein, FF Kreiner, N Marx, MA Nauck, ... Diabetes, Obesity and Metabolism 22 (9), 1537-1547, 2020 | 77 | 2020 |
| Statin use in relation to prostate cancer outcomes in a population‐based patient cohort study MS Geybels, JL Wright, SK Holt, S Kolb, Z Feng, JL Stanford The Prostate 73 (11), 1214-1222, 2013 | 70 | 2013 |
| Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue MS Geybels, S Zhao, CJ Wong, M Bibikova, B Klotzle, M Wu, ... The Prostate 75 (16), 1941-1950, 2015 | 63 | 2015 |
| Germline variation at 8q24 and prostate cancer risk in men of European ancestry M Matejcic, EJ Saunders, T Dadaev, MN Brook, K Wang, X Sheng, ... Nature communications 9 (1), 4616, 2018 | 60 | 2018 |
| Prostate tumor DNA methylation is associated with cigarette smoking and adverse prostate cancer outcomes IM Shui, CJ Wong, S Zhao, S Kolb, EM Ebot, MS Geybels, R Rubicz, ... Cancer 122 (14), 2168-2177, 2016 | 60 | 2016 |
| Selenoprotein gene variants, toenail selenium levels, and risk for advanced prostate cancer MS Geybels, PA van den Brandt, LJ Schouten, FJ van Schooten, ... Journal of the National Cancer Institute 106 (3), dju003, 2014 | 60 | 2014 |
| Advanced prostate cancer risk in relation to toenail selenium levels MS Geybels, BAJ Verhage, FJ van Schooten, RA Goldbohm, ... Journal of the National Cancer Institute 105 (18), 1394-1401, 2013 | 58 | 2013 |
| Oxidative stress–related genetic variants, pro-and antioxidant intake and Status, and advanced prostate cancer risk MS Geybels, PA Van Den Brandt, FJ Van Schooten, BAJ Verhage Cancer epidemiology, biomarkers & prevention 24 (1), 178-186, 2015 | 51 | 2015 |
| PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles MS Geybels, M Fang, JL Wright, X Qu, M Bibikova, B Klotzle, JB Fan, ... Oncotarget 8 (48), 84338, 2017 | 45 | 2017 |
| DNA methylation profiles in African American prostate cancer patients in relation to disease progression R Rubicz, S Zhao, M Geybels, JL Wright, S Kolb, B Klotzle, M Bibikova, ... Genomics 111 (1), 10-16, 2019 | 44 | 2019 |
| Quantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor β2 immunohistochemistry in prostate cancer AE Rizzardi, X Zhang, RI Vogel, S Kolb, MS Geybels, YK Leung, ... Diagnostic pathology 11, 1-11, 2016 | 43 | 2016 |
| Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors MS Geybels, JJ Alumkal, M Luedeke, A Rinckleb, S Zhao, IM Shui, ... Clinical epigenetics 7, 1-12, 2015 | 40 | 2015 |
| Variation in selenoenzyme genes and prostate cancer risk and survival MS Geybels, CM Hutter, EM Kwon, EA Ostrander, R Fu, Z Feng, ... The Prostate 73 (7), 734-742, 2013 | 38 | 2013 |
